OBSOLETE – Final Issued December 8, 2017FDA issued a draft guidance developed as part of the Internation Medical Device Regulators Forum entitled “Software as a Medical Device (SaMD): Clinical Evaluation”. This document focuses on how to demonstrate clinical validatity of software as a medical device. Other guidances from FDA and IMDRF address other software aspects such as software validation, premarket submissions, and risk classification among others.